Webinar September 28th, 2023To Sleep Perchance to Breathe : OSA and its impact on Morbidity and Mortality – by Dr. Najib Ayas

“Dear CLIMOA Members and Friends

I am happy to invite you to the next educational webinar of 2023 and excited, as I believe it will be as valuable to you as our webinars have been in the past. As you know, CLIMOA offers these webinars free of charge to the life and living benefits insurance community.

Plan to join us on Thursday, September 28 @ 11:00am ET – The topic of the webinar is:

To Sleep Perchance to Breathe: OSA and its Impact on Morbidity and Mortality

Our speaker is Dr. Najib Ayas who is the Medical Manager of the sleep program at the UBC Hospital in Vancouver, British Columbia and chair of the guideline committee for sleep disordered breathing at the Canadian Thoracic Society. After reviewing Dr. Ayas’ many past publications, it is clear that this is someone who has dedicated a large part of his career to the mortality and morbidity of obstructive sleep apnea and has a very clear understanding of this topic. 

CLICK HERE to register and we hope you can join us!

AMA: Use of BMI alone is an imperfect clinical measure

Body mass index (BMI) is easy to measure and inexpensive. It also has standardized cutoff points for overweight and obesity and is strongly correlated with body fat levels as measured by the most accurate methods. But BMI is an imperfect measure because it does not directly assess body fat.

Long COVID – One Year On

Long COVID is now a recognized complication of acute COVID-19 infection. As the COVID-19 pandemic moves into its third year, the prevalence of Long COVID continues to increase. Many individuals report symptoms lasting longer than a year, and a subset of this group is unable to work. This article will provide an update on Long COVID, with a particular focus on distinguishing it from other clinical entities. It will review several proposed disease mechanisms and will attempt to anticipate the impact on disability insurance.

Long COVID – An Early Perspective

A new syndrome called “Long COVID” has emerged amongst the survivors of acute COVID-19 infection. Its protracted and debilitating nature will almost certainly result in many short and long-term disability claims. Insurers need to understand the nature of Long COVID, including its definition, its prevalence, its natural history, and underlying risk factors. This article will summarize current knowledge of Long COVID and provide a perspective on its evolution and its impact.

Long Covid – Into the Third Year

As the COVID-19 pandemic reaches the end of its third year, and as COVID-related mortality in North America wanes, long Covid and its disabling symptoms are attracting more attention. Some individuals report symptoms lasting more than 2 years, and a subset report continuing disability. This article will provide an update on long Covid, with a particular focus on disease prevalence, disability, symptom clustering and risk factors. It will also discuss the longer-term outlook for individuals with long Covid.

By-Law No. 1

The Canadian Life Insurance Medical Officers Association Association Canadienne des Directeurs Medicaux en Assurance-Vie